ACT Brief: Bayesian Implementation, Women in Statistics, and FDA Tightens Gene Therapy Standards

In today's ACT Brief, we explore the operational capabilities clinical teams need to implement Bayesian trial designs, why gender diversity strengthens data science across drug development, and the FDA's rejection of external controls for a Huntington's gene therapy candidate.